Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.
Gemelli Biotech has raised $19.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Gemelli Biotech's investors include Cedars Sinai, Blue Ox Healthcare Partners, CerraCap Ventures, Carolina Angel Network.
Gemelli Biotech is headquartered in Raleigh, United States.
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.
Gemelli Biotech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gemelli Biotech — Funding & Investors." VCBacked, June 22, 2022, https://www.vcbacked.co/company/gemelli-biotech. Accessed September 30, 2026.
VCBacked. (2022). Gemelli Biotech — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/gemelli-biotech
{{cite web |title=Gemelli Biotech — Funding & Investors |url=https://www.vcbacked.co/company/gemelli-biotech |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated